Final results of a phase 1b study of the safety and efficacy of the PI3K delta inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies

AP Kater; SH Tonino; M Spiering; MED Chamuleau; R Liu; AH Adewoye; J Gao; L Dreiling; Y Xin; Jeanette Doorduijn; MJ Kersten

doi:10.1038/s41408-018-0055-x

Final results of a phase 1b study of the safety and efficacy of the PI3K delta inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies

AP Kater
, SH Tonino
, M Spiering
, MED Chamuleau
, R Liu
, AH Adewoye
, J Gao
, L Dreiling
, Y Xin
, Jeanette Doorduijn
, MJ Kersten

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

Original language	Undefined/Unknown
Article number	16
Journal	Blood Cancer Journal
Volume	8
DOIs	https://doi.org/10.1038/s41408-018-0055-x
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1038/s41408-018-0055-x

Cite this

Kater, AP., Tonino, SH., Spiering, M., Chamuleau, MED., Liu, R., Adewoye, AH., Gao, J., Dreiling, L., Xin, Y., Doorduijn, J., & Kersten, MJ. (2018). Final results of a phase 1b study of the safety and efficacy of the PI3K delta inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies. Blood Cancer Journal, 8, Article 16. https://doi.org/10.1038/s41408-018-0055-x

@article{0e4b96ff16fe46c98e0649c6bb6d796f,

title = "Final results of a phase 1b study of the safety and efficacy of the PI3K delta inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies",

author = "AP Kater and SH Tonino and M Spiering and MED Chamuleau and R Liu and AH Adewoye and J Gao and L Dreiling and Y Xin and Jeanette Doorduijn and MJ Kersten",

year = "2018",

doi = "10.1038/s41408-018-0055-x",

language = "Undefined/Unknown",

volume = "8",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Final results of a phase 1b study of the safety and efficacy of the PI3K delta inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies

AU - Kater, AP

AU - Tonino, SH

AU - Spiering, M

AU - Chamuleau, MED

AU - Liu, R

AU - Adewoye, AH

AU - Gao, J

AU - Dreiling, L

AU - Xin, Y

AU - Doorduijn, Jeanette

AU - Kersten, MJ

PY - 2018

Y1 - 2018

U2 - 10.1038/s41408-018-0055-x

DO - 10.1038/s41408-018-0055-x

M3 - Article

C2 - 29434192

SN - 2044-5385

VL - 8

JO - Blood Cancer Journal

JF - Blood Cancer Journal

M1 - 16

ER -